Brief: Genocea Biosciences Inc - Qtrly Loss Per Share of $0.17
29/04/2021 12:43
April 29 (Reuters) - Genocea Biosciences Inc GNCA.O :
* GENOCEA BIOSCIENCES INC - GENOCEA'S OPERATING PLAN EXTENDS
ITS
CASH RUNWAY TO END OF 2022
* GENOCEA BIOSCIENCES INC QTRLY LOSS PER SHARE $0.17
Source text for Eikon: ID:nGNXbCR8Cl
Further company coverage: GNCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genocea Biosciences
See all newsBluebird, Chimerix, Clovis have under 6 months of cash left - Truist
Genocea Biosciences plunges as it winds down operations
Brief: Genocea Announces Wind Down Of Operations And Delisting From Nasdaq
Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Oppenheimer Holdings, IES Holdings Inc, Avantor Inc